Prot # D3250C00020:A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Efficacy and Safety Study of Benralizumab (MEDI-563) to Reduce Oral Corticosteroid Use in Patients with Uncontrolled Asthma on High Dose Inhaled Cortic

  • Avila, Pedro C (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date1/8/151/8/18

Funding

  • AstraZeneca Pharmaceuticals LP (D3250C00020)